Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 8, 2011, Pages 869-887

  Glatt, Stephen J ^a   Stone, William S ^b,c   Nossova, Nadine ^d   Liew, Choong Chin ^d   Seidman, Larry J ^b,c   Tsuang, Ming T ^c,e,f  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d GeneNews Ltd   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Gene expression; Histone; Microarray; Transcriptome; Unaffected relatives

Indexed keywords

HISTONE; MESSENGER RNA;

ADULT; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; MALE; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RELATIVE; RISK ASSESSMENT; SCHIZOPHRENIA; SIBLING;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FAMILY; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HISTONES; HUMANS; MALE; MIDDLE AGED; NUCLEOSOMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SCHIZOPHRENIA; TRANSCRIPTOME;

EID: 80054850997     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31239     Document Type: Article

References (47)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40(7): 827-834.
2. Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, et al. 2004. UniProt: The universal protein knowledgebase. Nucleic Acid Res 32(Database issue): D115-D119.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1): 25-29.
4. Baumeister AA, Francis JL. 2002. Historical development of the dopamine hypothesis of schizophrenia. J Hist Neurosci 11(3): 265-277.
5. Brown IR, Liew CC. 1975. Lysergic acid diethylamide: Effect on histone acetylation in rabbit brain. Science 188(4193): 1122-1123.
6. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Mintz J, et al. 2007. The consortium on the genetics of endophenotypes in schizophrenia (COGS): "Model" recruitment, assessment and endophenotyping methods for a multi-site collaboration. Schizophr Bull 33: 33-48.
7. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, et al. 1999. Heritability estimates for psychotic disorders. Arch Gen Psychiatry 56: 162-168.
8. Deng X, Xu J, Wang C. 2008. Improving the power for detecting overlapping genes from multiple DNA microarray-derived gene lists. BMC Bioinformatics 9(Suppl 6): S14.
9. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4(5): P3.
10. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, et al. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40(9): 1056-1058.
11. Glatt SJ, Jonsson EG. 2006. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed- and random-effects meta-analyses. Am J Med Genet Part B 141B(2): 149-154.
12. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasik R, Khanlou N, Han M, Liew CC, Tsuang MT. 2005a. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci USA 102(43): 15533-15538.
13. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasik R, Khanlou N, Han M, Liew CC, Tsuang MT. 2005b. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci USA 102: 15533-15538.
14. Glatt SJ, Faraone SV, Tsuang MT. 2007. Genetic risk factors for mental disorders: General principles and state of the science. In: Tsuang MT, Stone WS, Lyons MJ, editors. Recognition and prevention of major mental and substance use disorders. Washington, DC: American Psychiatric Publishing, Inc. pp. 3-20.
15. Glatt SJ, Faraone SV, Lasky-Su JA, Kanazawa T, Hwu H-G, Tsuang MT. 2009. Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Mol Psychiatry 14: 885-893.
16. Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, Gordon-Smith K, Fraser C, Forty L, Russell E, et al. 2009. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15(10): 1016-1022.
17. Handran S, Pickett S, Verdick D. 2002. Key considerations for accurate microarray scanning and image analysis. In: Kamberova G, Shah S, editors. DNA array image analysis: Nuts & bolts. Salem, MA: DNA Press, LLC. pp. 83-98.
18. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P, Das U, Daugherty L, Duquenne L, et al. 2009. InterPro: The integrative protein signature database. Nucleic Acid Res 37(Database issue): D211-D215.
19. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2): 249-264.
20. Jastak S, Wilkinson G. 1993. Wide Range achievement test-Revised 3. Wilmington, DE: Jastak Associates.
21. Kanehisa M, Goto S. 2000. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acid Res 28(1): 27-30.
22. Mansour HA, Wood J, Logue T, Chowdari KV, Dayal M, Kupfer DJ, Monk TH, Devlin B, Nimgaonkar VL. 2006. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 5(2): 150-157.
23. Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, et al. 2009. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord 11(7): 701-710.
24. Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E. 2009. Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. BMC Psychiatry 9: 17.
25. Meaburn EL, Fernandes C, Craig IW, Plomin R, Schalkwyk LC. 2009. Assessing individual differences in genome-wide gene expression in human whole blood: Reliability over four hours and stability over 10 months. Twin Res Hum Genet 12(4): 372-380.
26. Minoretti P, Politi P, Coen E, Di Vito C, Bertona M, Bianchi M, Emanuele E. 2006. The T393C polymorphism of the GNAS1 gene is associated with deficit schizophrenia in an Italian population sample. Neurosci Lett 397(1-2): 159-163.
27. Nimgaonkar VL, Ganguli R, Rudert WA, Vavassori C, Rabin BS, Trucco M. 1993. A negative association of schizophrenia with an allele of the HLA DQB1 gene among African-Americans. Schizophr Res 8(3): 199-209.
28. Nimgaonkar VL, Rudert WA, Zhang X, Trucco M, Ganguli R. 1997. Negative association of schizophrenia with HLA DQB1*0602: Evidence from a second African-American cohort. Schizophr Res 23(1): 81-86.
29. NIMH Genetics Initiative. 1992. Family interview for genetic studies. Rockville: National Institute of Mental Health.
30. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T, Miller M, et al. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. Arch Gen Psychiatry 51: 849-859.
31. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40(9): 1053-1055.
32. Sarras H, Semeralul MO, Fadel MP, Feldcamp LA, Labrie V, Wong AH. 2010. Elevated PICK1 mRNA in schizophrenia increased SRR mRNA in suicide. Schizophr Res 120(1-3): 236-237.
33. Schultz J, Milpetz F, Bork P, Ponting CP. 1998. SMART, a simple modular architecture research tool: Identification of signaling domains. Proc Natl Acad Sci USA 95(11): 5857-5864.
34. Schwab SG, Hallmayer J, Freimann J, Lerer B, Albus M, Borrmann-Hassenbach M, Segman RH, Trixler M, Rietschel M, Maier W, et al. 2002. Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia. Am J Med Genet 114(3): 315-320.
35. Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, et al. 2005. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci USA 102(9): 3513-3518.
36. Segal D, Koschnick JR, Slegers LH, Hof PR. 2007. Oligodendrocyte pathophysiology: A new view of schizophrenia. Int J Neuropsychopharmacol 10(4): 503-511.
37. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460(7256): 753-757.
38. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460(7256): 744-747.
39. Sullivan PF, Kendler KS, Neale MC. 2003. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60(12): 1187-1192.
40. Sullivan PF, Fan C, Perou CM. 2006. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet Part B 141B(3): 261-268.
41. Takahashi M, Hayashi H, Watanabe Y, Sawamura K, Fukui N, Watanabe J, Kitajima T, Yamanouchi Y, Iwata N, Mizukami K, et al. 2010. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr Res 119(1-3): 210-218.
42. Talkowski ME, Kirov G, Bamne M, Georgieva L, Torres G, Mansour H, Chowdari KV, Milanova V, Wood J, McClain L, et al. 2008. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 17(5): 747-758.
43. Tatusov RL, Galperin MY, Natale DA, Koonin EV. 2000. The COG database: A tool for genome-scale analysis of protein functions and evolution. Nucleic Acid Res 28(1): 33-36.
44. Tsuang MT, Nossova N, Yager T, Tsuang M-M, Guo S-C, Shyu KG, Glatt SJ, Liew CC. 2005. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary report. Am J Med Genet Part B 133B: 1-5.
45. Van Rossum JM. 1967. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In: Brill H, Cole J, Deniker P, Hippius H, Bradley PB, editors. Neuropsychopharmacology, Proceedings 5th Collegium Internationale Neuropsychopharmacologicum. Amsterdam: Excerpta Medica Foundation. pp. 321-329.
46. Wu CH, Yeh LS, Huang H, Arminski L, Castro-Alvear J, Chen Y, Hu Z, Kourtesis P, Ledley RS, Suzek BE, et al. 2003. The protein information resource. Nucleic Acid Res 31(1): 345-347.
47. Zvara A, Szekeres G, Janka Z, Kelemen JZ, Cimmer C, Santha M, Puskas LG. 2005. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers. Dis Markers 21(2): 61-69.